Biohaven Ltd (NYSE:BHVN)
$ 38.59 -0.13 (-0.34%) Market Cap: 3.41 Bil Enterprise Value: 3.16 Bil PE Ratio: 0 PB Ratio: 10.46 GF Score: 21/100

Q2 2020 Biohaven Pharmaceutical Holding Company Ltd Earnings Call Transcript

Aug 10, 2020 / 12:00PM GMT
Operator

Good morning, ladies and gentlemen, and welcome to the Biohaven Pharmaceuticals Second Quarter 2020 Results Call. (Operator Instructions) Please be advised that today's conference may be recorded.

I would now like to hand the conference over to Biohaven's Chief Operating Officer, Clifford Bechtold. Thank you, and please go ahead.

Clifford Bechtold
Biohaven Pharmaceutical Holding Company Ltd. - President & GM of Biohaven Ireland and Chief Compliance Officer

Good morning. Thank you, and welcome to the Second Quarter 2020 Earnings Call. Speaking today are -- sorry, speaking this morning on today's call is Dr. Vlad Coric, our Chief Executive Officer; Jim Engelhart, Chief Financial Officer; BJ Jones, our Chief Commercial Officer; and Elyse Stock, our Clinical Medical Officer.

Earlier this morning, we issued a press release announcing our second quarter 2020 highlights. A copy of this press release can be found on our website at biohavenpharma.com.

Before we begin today's presentation, I would like to remind you that various remarks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot